Almoosa Health Company Statistics

Total Valuation

TADAWUL:4018 has a market cap or net worth of SAR 7.30 billion. The enterprise value is 7.53 billion.

Market Cap	7.30B
Enterprise Value	7.53B

Important Dates

The next estimated earnings date is Wednesday, May 28, 2025.

Earnings Date	May 28, 2025
Ex-Dividend Date	n/a

Share Statistics

TADAWUL:4018 has 44.30 million shares outstanding.

Current Share Class	44.30M
Shares Outstanding	44.30M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+2.77%
Owned by Insiders (%)	0.00%
Owned by Institutions (%)	0.03%
Float	13.29M

Valuation Ratios

The trailing PE ratio is 46.41 and the forward PE ratio is 34.22. TADAWUL:4018's PEG ratio is 1.13.

PE Ratio	46.41
Forward PE	34.22
PS Ratio	5.85
PB Ratio	3.82
P/TBV Ratio	3.84
P/FCF Ratio	n/a
P/OCF Ratio	36.61
PEG Ratio	1.13

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 26.54, with an EV/FCF ratio of -86.15.

EV / Earnings	57.12
EV / Sales	6.03
EV / EBITDA	26.54
EV / EBIT	37.71
EV / FCF	-86.15

Financial Position

The company has a current ratio of 2.67, with a Debt / Equity ratio of 0.32.

Current Ratio	2.67
Quick Ratio	2.38
Debt / Equity	0.32
Debt / EBITDA	2.17
Debt / FCF	-7.02
Interest Coverage	2.85

Financial Efficiency

Return on equity (ROE) is 10.33% and return on invested capital (ROIC) is 5.63%.

Return on Equity (ROE)	10.33%
Return on Assets (ROA)	4.65%
Return on Invested Capital (ROIC)	5.63%
Return on Capital Employed (ROCE)	7.55%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	2,884
Asset Turnover	0.47
Inventory Turnover	12.31

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	156.83
200-Day Moving Average	n/a
Relative Strength Index (RSI)	54.63
Average Volume (20 Days)	81,558

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TADAWUL:4018 had revenue of SAR 1.25 billion and earned 131.83 million in profits. Earnings per share was 3.55.

Revenue	1.25B
Gross Profit	388.56M
Operating Income	198.72M
Pretax Income	134.61M
Net Income	131.83M
EBITDA	275.58M
EBIT	198.72M
Earnings Per Share (EPS)	3.55

Full Income Statement

Balance Sheet

The company has 385.32 million in cash and 613.60 million in debt, giving a net cash position of -228.28 million or -5.15 per share.

Cash & Cash Equivalents	385.32M
Total Debt	613.60M
Net Cash	-228.28M
Net Cash Per Share	-5.15
Equity (Book Value)	1.91B
Book Value Per Share	43.72
Working Capital	624.70M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 199.44 million and capital expenditures -286.84 million, giving a free cash flow of -87.40 million.

Operating Cash Flow	199.44M
Capital Expenditures	-286.84M
Free Cash Flow	-87.40M
FCF Per Share	-1.97

Full Cash Flow Statement

Margins

Gross margin is 31.13%, with operating and profit margins of 15.92% and 10.56%.

Gross Margin	31.13%
Operating Margin	15.92%
Pretax Margin	10.78%
Profit Margin	10.56%
EBITDA Margin	22.08%
EBIT Margin	15.92%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 0.61%.

Dividend Per Share	1.00
Dividend Yield	0.61%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	7.59%
Buyback Yield	n/a
Shareholder Yield	0.61%
Earnings Yield	1.81%
FCF Yield	-1.20%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a